Hyperbaric Oxygen Therapy for Optic Neuropathies
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University
About this trial
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Eligibility criteria
Qualifiers
Participant must be at least 18.
Participant must has the ability to comply with the requirements of the study and complete the schedule of events (SOE).
Participant's with clinical evidence of optic neuropathy.
Participant must understand and sign the informed consent. If the participant's vision is impaired to the point where he/she cannot read the informed consent document, the document will be read to the participant in its entirety.
Disqualifiers
Participant is unable to comply with study procedures or follow-up visits.
Participant has evidence of corneal opacification or lack of optical clarity.
Participant is currently participating in or has within the last 3 months participated in any other clinical trial of a drug by ocular (if in the study eye) or systemic administration.
Participant is pregnant or lactating.
Trial design
Treatments tested in this trial
- Hyperbaric Oxygen
- Sham Hyperbaric Oxygen
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov